GlassScriptPhysician profile
Abby Cahill
NPI 1275157315
$9,899.48
in general payments reported to CMS, 2019-2025
49 companies · $1,761 in 2025
The $1,761 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,828 · 2022: $2,353 · 2023: $1,663 · 2024: $2,295 · 2025: $1,761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,520 · Education: $157 · Travel and Lodging: $26.09 · Entertainment: $15.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,519.54 |
| Education | $157.00 |
| Travel and Lodging | $26.09 |
| Entertainment | $15.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,372.75 | 2021-2025 | Erleada, Rybrevant, Carvykti |
| Medtronic, INC. | $1,258.26 | 2021-2025 | Interstim |
| Dendreon Pharmaceuticals LLC | $586.23 | 2021-2025 | Provenge |
| Astellas Pharma US INC | $565.16 | 2021-2025 | Xtandi, Veozah, Myrbetriq |
| Endo Pharmaceuticals INC. | $560.70 | 2021-2024 | Xiaflex, Aveed |
| Pfizer INC. | $446.53 | 2021-2025 | |
| Rochester Medical Corporation | $425.19 | 2022 | |
| Myovant Sciences INC. | $423.98 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $325.52 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $309.20 | 2021-2025 | |
| Johnson & Johnson Health Care Systems INC. | $261.15 | 2024-2025 | Darzalex, Stelara |
| Coloplast Corp | $222.63 | 2021-2023 | Titan |
| Angiodynamics, INC. | $216.44 | 2024 | Nanoknife |
| Clarus Therapeutics INC. | $209.82 | 2021 | |
| Innovation Technologies INC | $206.12 | 2022-2024 | Irrisept |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $179.44 | 2021-2024 | Axonics, Bulkamid |
| Antares Pharma, INC. | $176.63 | 2021-2025 | Xyosted |
| 180 Medical, INC. | $150.25 | 2022-2023 | Gentlecath |
| Olympus America INC. | $143.18 | 2022-2025 | Itind System |
| Merck Sharp & Dohme LLC | $140.68 | 2021-2025 | Keytruda, Lynparza |
| Endo USA, INC. | $126.37 | 2024-2025 | Xiaflex, Aveed |
| Teleflex LLC | $125.35 | 2021-2023 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $123.06 | 2021-2025 | |
| Boston Scientific Corporation | $118.03 | 2022-2025 | Rezum Generator, Bulkamid, General - Erectile Dysfunction |
| Blue Earth Diagnostics | $104.09 | 2021-2024 | |
| Ferring Pharmaceuticals INC. | $100.73 | 2024-2025 | Adstiladrin |
| Verity Pharmaceuticals INC. | $97.77 | 2024-2025 | Trelstar |
| Myriad Genetic Laboratories, INC. | $96.88 | 2023-2025 | Prolaris |
| Progenics Pharmaceuticals, INC. | $86.46 | 2022-2024 | Pylarify |
| Urogen Pharma, INC. | $82.55 | 2021-2024 | |
| Tolmar, INC. | $80.67 | 2023-2024 | |
| Tolmar Pharmaceuticals, INC. | $77.89 | 2021-2022 | |
| Accord Healthcare, INC. | $60.28 | 2024-2025 | |
| Kerecis Limited | $43.98 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Eisai INC. | $43.88 | 2022-2023 | |
| Azurity Pharmaceuticals, INC. | $42.37 | 2025 | Azmiro |
| Halozyme INC | $41.56 | 2023 | |
| Valencia Technologies Corporation | $41.18 | 2025 | Ecoin Device Kit |
| Urovant Sciences INC | $37.64 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $24.43 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $21.83 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $20.67 | 2025 | |
| Genzyme Corporation | $20.16 | 2022 | |
| Hollister Incorporated | $19.38 | 2022 | |
| Procept Biorobotics Corporation | $19.19 | 2024 | Aquabeam System |
| Acerus Pharmaceuticals Corporation | $16.42 | 2021 | |
| Provepharm INC. | $15.87 | 2024 | Bludigo |
| Kowa Pharmaceuticals America, INC. | $15.79 | 2023 | Seglentis |
| Photocure INC | $15.14 | 2024 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Cahill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.